Your session is about to expire
← Back to Search
mRNA-1283.211 for COVID-19
Study Summary
This trial is testing the safety and effectiveness of two possible vaccines for COVID-19.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What other research has been conducted using mRNA-1283.211?
"The original research on mRNA-1283.211 was conducted in 2020 by the Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases. So far, 8 studies have been completed with 28 more currently underway; a large portion of these are based in Phoenix, Arizona."
What other similar research projects exist for comparison?
"Since 2020, mRNA-1283.211 has undergone extensive clinical trials. The first of these was sponsored by ModernaTX, Inc and took place in that same year. It involved 120 people and resulted in Phase 1 approval for the drug. Currently, there are 28 active studies being conducted in 219 cities across 22 nations."
Are there any remaining slots available for participants in this research?
"According to the latest information available on clinicaltrials.gov, this particular trial is not currently looking for patients. This study was originally posted December 6th, 2021 and has had recent activity on September 22nd, 2022. Although this one isn't enrolling right now, there are 1,151 other trials that are searching for participants at this time."
How does mRNA-1283.211 compare to other treatments in terms of safety?
"mRNA-1283.211 is still in Phase 2 clinical trials, so there is not yet data supporting its efficacy. However, there is some evidence that it may be safe, which gives it a score of 2."
In how many different medical facilities is this research project being conducted currently?
"This trial is recruiting patients at 17 different locations, including MedPharmics, LLC in Phoenix, Rochester Clinical Research, Inc. in Rochester, and MedPharmics in Metairie."
Could you please give the total number of people signing up for this clinical trial?
"No, this research project is not looking for volunteers at the moment. The trial was first advertised on December 6th 2021 and was last updated September 22nd 2022. If you are interested in other studies, please note that there are 1123 trials actively recruiting participants with covid-19 and 28 mRNA-1283.211 trials also seeking volunteers."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger